echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Antitumor Therapy > Br J Cancer: The level of estrogen in urine can be used as a risk indicator for the development of prostate cancer

    Br J Cancer: The level of estrogen in urine can be used as a risk indicator for the development of prostate cancer

    • Last Update: 2021-04-16
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Prostate cancer (PCa) is the second most common cancer among men worldwide.


    Prostate cancer (PCa) is the second most common cancer among men worldwide.


    Therefore, the study aims to explore the correlation between the level of estrogen in urine and the clinical outcome of patients.


    The study aims to explore the correlation between the level of estrogen in urine and the clinical outcome of patients.


    The researchers collected urine samples from patients before radical prostatectomy (RP) in the prospective multi-institution PROCURE cohort, and set up a discovery cohort (n=259) and a verification cohort (n=253) two cohort studies .


    The biotransformation model of estrogen and its related derivatives

    The biotransformation model of estrogen and its related derivatives

    The results showed that the median follow-up time for the discovery and verification cohorts were 7.


    Correlation of estrogen in urine of patients with prostate cancer

    Correlation of estrogen in urine of patients with prostate cancer

    All in all, the results of the study revealed that the levels of estriol and 16-ketoestradiol metabolites in urine are associated with a more favorable outcome for patients, while the level of 2-methoxyestrone is associated with the risk of metastasis after RP.


    The results of the study revealed that urine levels of estriol and 16-ketoestradiol metabolites are associated with more favorable outcomes for patients, while 2-methoxyestrone levels are associated with increased risk of metastasis after RP Related.



    org/10.




    Leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.